Amyris and BASF to partner on R&D

|By:, SA News Editor

Usually announcements like this don't move the needle much but shares of Amyris (AMRS +15.6%) are up nicely this morning in apparent response to its collaboration with BASF.

The company will use its synthetic biology and strain engineering platform to develop a microorganism capable of producing a BASF-targeted molecule.

No financial terms are disclosed.